WELCOME

The Department of Pharmacology and Cancer Biology was created to foster collaborative interactions between scientists with different, though complementary, research interests and expertise. The primary goal in developing such an interdisciplinary department was to create an environment where rigorous scientific debate and discourse between researchers with different perspectives would create a stimulating and productive intellectual environment for faculty and trainees alike. As you browse through the research descriptions of our faculty and appreciate the breadth and significance of their scientific achievements, it should become clear that this experiment was a tremendous success. Research projects address a myriad of important scientific questions relevant to cancer, metabolism, nervous system function, drugs of abuse, and environmental toxicants. However, one unifying theme that has emerged in the department is cell signaling and the use of pharmacological approaches to define the key regulatory steps in relevant pathways that may be amenable to pharmaceutical exploitation or whose dysregulation may be involved in the pathogenesis of disease. It is a privilege to welcome you to our website and we encourage you to learn more about the opportunities in research, training, and education offered by this exciting and dynamic department.
 
Donald P. McDonnell, Ph.D.
Professor and Chairman
 

UPCOMING SEMINARS

  • Wednesday, February 10, 2016 at 12:00 pm

  • Mitch Lazar, MD, PhD, University of Pennsylvania
  • “Transcriptional links between circadian rhythms and metabolism”
  • 103 Bryan Research
  • Wednesday, February 17, 2016 at 12:00 pm

  • Dave D'Alessio, MD, Duke
  • “Is GLP-1 a hormone: Whether and when?”
  • 103 Bryan Research
  • Wednesday, March 9, 2016 at 12:00 pm

  • Maria Barna, PhD, Stanford University
  • “Specialized ribosomes: A new frontier in gene regulation, organismal development and evolution”
  • 103 Bryan Research
  • Wednesday, March 16, 2016 at 12:00 pm

  • Alejandro Sweet-Cordero, MD, Stanford University
  • “Genomic analysis of pediatric cancer - basic discovery and clinical applications”
  • 103 Bryan Research
  • Wednesday, March 30, 2016 at 12:00 pm

  • Benjamin Neel, MD, PhD, NYU School of Medicine
  • “Emergent vulnerabilities in breast cancer”
  • 103 Bryan Research
[ All Upcoming Seminars ]

© 2012 Pharmacology and Cancer Biology. Duke University School of Medicine. Site design: Academic Web Pages